We are live on
!
Find out more
Rigel Pharmaceuticals
RIGL
RIGL
159 hedge funds and large institutions have $433M invested in Rigel Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 73 increasing their positions, 48 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
61% more call options, than puts
Call options by funds: $2.28M | Put options by funds: $1.41M
52% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 48
2.27% less ownership
Funds ownership: 88.92% → 86.65% (-2.3%)
18% less funds holding
Funds holding: 193 → 159 (-34)
37% less capital invested
Capital invested by funds: $691M → $433M (-$258M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
64% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 47
Holders
159
Holders Change
-34
Holders Change %
-17.62%
% of All Funds
1.96%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
17
Increased
73
Reduced
48
Closed
47
Calls
$2.28M
Puts
$1.41M
Net Calls
+$868K
Net Calls Change
-$5.01M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$14.9M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$9.74M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5.81M |
| 4 |
Two Sigma Investments
New York
|
+$4.52M |
| 5 |
BlackRock
New York
|
+$3.52M |
Top Sellers
| 1 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$12.1M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$9.75M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$8.28M |
| 4 |
Goldman Sachs
New York
|
-$7.82M |
| 5 |
Jane Street
New York
|
-$6.91M |
